Comparing the current results to its competitors, Nephros Inc reported Revenue increase in the 2 quarter 2026 by 58.55 % year on year. The sales growth was above Nephros Inc 's competitors' average revenue growth of 4.23 %, achieved in the same quarter.
Nephros Inc 's Comment on Competition and Industry Peers
The company operates in the water filtration market, competing with firms such as Cytiva (formerly Pall Corporation), Aquatools, Aquamedix, i3, 3M Company, and Pentair. It focuses on designing and commercializing point-of-use filtration solutions for high-risk applications. The company emphasizes validated performance, reliability, and ease of use in mission-critical environments. It also employs a patent strategy covering hardware design and methods of hemodiafiltration to maintain its competitive position.
Outset Medical Inc's business model revolves around the production and distribution of innovative medical devices for kidney dialysis. With a focus on patient-centric care, their flagship product Tablo simplifies dialysis and allows for it to be performed in various clinical settings, including hospitals, clinics, and homes. By offering a comprehensive solution that combines hardware, software, and support services, Outset Medical aims to improve the dialysis experience for both healthcare providers and patients.
Rockwell Medical Inc operates with a business model focused on developing, manufacturing, and marketing innovative medical products and therapies. The company aims to address critical health challenges by providing proprietary dialysis solutions and iron maintenance therapies. Their approach includes collaborating with healthcare providers to improve patient outcomes and enhance the standards of care in chronic kidney disease management.
Regeneron Pharmaceuticals Inc operates a business model centered on the discovery and commercialization of cutting-edge biopharmaceuticals, particularly in the fields of ophthalmology, oncology, immunology, and rare diseases. They leverage their strong research and development capabilities, including their proprietary technologies, to create innovative therapies that address unmet medical needs. Additionally, Regeneron forms strategic collaborations and partnerships to enhance their development pipeline and expand market access for their products.
Pentair Plc operates as a diversified industrial company focused on delivering sustainable water solutions and fluid management systems. Its business model emphasizes the design, manufacture, and distribution of a diverse portfolio of products that facilitate the movement, treatment, storage of water, and thermal management across various industries.
3M Company operates a diversified business model by offering innovative solutions across multiple segments, including healthcare, safety and industrial, transportation, and consumer goods. The company leverages its extensive portfolio of patents and deep customer relationships to drive product development and market responsiveness, focusing on delivering value across various industries.
Sources:
Nephros Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Nephros Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
